peptide (CNP): cardiovascular roles and potential as a therapeutic target. Curr Pharm Des. 2010;16(37):4080-8. \[[PMC free article: PMC3605774](/pmc/articles/PMC3605774/)\] \[[PubMed: 21247399](https://pubmed.ncbi.nlm.nih.gov/21247399)\] 13. Yasoda A, Nakao K. Translational Research of the Activation of the C-Type Natriuretic Peptide (CNP)-Guanylyl Cyclase-B Pathway for Skeletal Dysplasia. In: Nakao K, Minato N, Uemoto S, editors. Innovative Medicine: Basic Research and Development [Internet]. Springer; Tokyo: 2015. pp. 177–186. \[[PubMed: 29787172](https://pubmed.ncbi.nlm.nih.gov/29787172)\] 14. Potter LR, Yoder AR, Flora DR, Antos LK, Dickey DM. Natriuretic peptides: their structures, receptors, physiologic functions and therapeutic applications. Handb Exp Pharmacol. 2009;(191):341-66. \[[PMC free article: PMC4855512](/pmc/articles/PMC4855512/)\] \[[PubMed: 19089336](https://pubmed.ncbi.nlm.nih.gov/19089336)\] 15. Schulz S, Waldman SA. The guanylyl cyclase family of natriuretic peptide receptors. Vitam Horm. 1999;57:123-51. \[[PubMed: 10232048](https://pubmed.ncbi.nlm.nih.gov/10232048)\] 16. Goetze JP, Bruneau BG, Ramos HR, Ogawa T, de Bold MK, de Bold AJ. Cardiac natriuretic peptides. Nat Rev Cardiol. 2020 Nov;17(11):698-717. \[[PubMed: 32444692](https://pubmed.ncbi.nlm.nih.gov/32444692)\] 17. Kuwahara K, Nakao K. Regulation and significance of atrial and brain natriuretic peptides as cardiac hormones. Endocr J. 2010;57(7):555-65. \[[PubMed: 20571250](https://pubmed.ncbi.nlm.nih.gov/20571250)\] 18. Kuwahara K, Nakagawa Y, Nishikimi T. Cutting Edge of Brain Natriuretic Peptide (BNP) Research - The Diversity of BNP Immunoreactivity and Its Clinical Relevance. Circ J. 2018 Sep 25;82(10):2455-2461. \[[PubMed: 30135320](https://pubmed.ncbi.nlm.nih.gov/30135320)\] 19. Omland T. Advances in congestive heart failure management in the intensive care unit: B-type natriuretic peptides in evaluation of acute heart failure. Crit Care Med. 2008 Jan;36(1 Suppl):S17-27. \[[PubMed: 18158473](https://pubmed.ncbi.nlm.nih.gov/18158473)\] 20. Abuzaanona A, Lanfear D. Pharmacogenomics of the Natriuretic Peptide System in Heart Failure. Curr Heart Fail Rep. 2017 Dec;14(6):536-542. \[[PMC free article: PMC5681877](/pmc/articles/PMC5681877/)\] \[[PubMed: 29075957](https://pubmed.ncbi.nlm.nih.gov/29075957)\] 21. Dobaczewski M, Chen W, Frangogiannis NG. Transforming growth factor (TGF)-β signaling in cardiac remodeling. J Mol Cell Cardiol. 2011 Oct;51(4):600-6. \[[PMC free article: PMC3072437](/pmc/articles/PMC3072437/)\] \[[PubMed: 21059352](https://pubmed.ncbi.nlm.nih.gov/21059352)\] 22. Ellmers LJ, Knowles JW, Kim HS, Smithies O, Maeda N, Cameron VA. Ventricular expression of natriuretic peptides in Npr1(-/-) mice with cardiac hypertrophy and fibrosis. Am J Physiol Heart Circ Physiol. 2002 Aug;283(2):H707-14. \[[PMC free article: PMC4321891](/pmc/articles/PMC4321891/)\] \[[PubMed: 12124219](https://pubmed.ncbi.nlm.nih.gov/12124219)\] 23. Maries L, Manitiu I. Diagnostic and prognostic values of B-type natriuretic peptides (BNP) and N-terminal fragment brain natriuretic peptides (NT-pro-BNP). Cardiovasc J Afr. 2013 Aug;24(7):286-9. \[[PMC free article: PMC3807675](/pmc/articles/PMC3807675/)\] \[[PubMed: 24217307](https://pubmed.ncbi.nlm.nih.gov/24217307)\] 24. Christoffersen C, Goetze JP, Bartels ED, Larsen MO, Ribel U, Rehfeld JF, Rolin B, Nielsen LB. Chamber-dependent expression of brain natriuretic peptide and its mRNA in normal and diabetic pig heart. Hypertension. 2002 Jul;40(1):54-60. \[[PubMed: 12105138](https://pubmed.ncbi.nlm.nih.gov/12105138)\] 25. Pfister R, Scholz M, Wielckens K, Erdmann E, Schneider CA. Use of NT-proBNP in routine